Answers are grounded in this paper and cite their sources.
Background: The clinical benefits of glutamine supplementation in patients with burn injuries remain uncertain. Although glutamine has been proposed to support immune function and recovery, its effects on major clinical outcomes are inconsistent.Objectives: This systematic review and meta-analysis evaluated the effects of glutamine supplementation on hospital length of stay, all-cause mortality, and systemic infectious complications in patients with burn injuries.Methods: PubMed/MEDLINE, Scopus, and the Cochrane Library were searched through July 26, 2026, for randomized controlled trials comparing glutamine supplementation with placebo or standard care. The review was registered in PROSPERO (CRD420261461723). Pooled estimates were calculated using random-effects models.Results: Eleven randomized controlled trials involving 1,662 participants were included. No statistically significant reductions were detected in hospital length of stay (mean difference, −3.22 days; 95% CI, −7.62 to 1.19), all-cause mortality (odds ratio, 0.92; 95% CI, 0.69–1.23), or systemic infectious complications (odds ratio, 0.97; 95% CI, 0.75–1.25). Heterogeneity was substantial for hospital length of stay (I² = 89%).Conclusions: The pooled findings did not demonstrate a clear benefit of routine glutamine supplementation for these outcomes in patients with burn injuries. Interpretation remains limited by heterogeneity and uncertainty in the included evidence.
No takes yet. Share an insight, caveat, or question.
Prabandari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: